(19)
(11) EP 1 680 116 A1

(12)

(43) Date of publication:
19.07.2006 Bulletin 2006/29

(21) Application number: 04791298.5

(22) Date of filing: 22.10.2004
(51) International Patent Classification (IPC): 
A61K 31/454(2000.01)
A61K 31/343(2000.01)
A61K 31/352(2000.01)
A61K 31/16(1985.01)
A61K 31/4164(2000.01)
A61K 31/4965(2000.01)
A61K 31/4166(2000.01)
A61K 31/785(1985.01)
A61K 31/5355(2000.01)
A61K 31/05(1985.01)
A61K 31/353(2000.01)
A61K 31/165(1985.01)
A61K 31/397(2000.01)
A61K 31/497(2000.01)
A61K 31/365(1985.01)
(86) International application number:
PCT/EP2004/052643
(87) International publication number:
WO 2005/039579 (06.05.2005 Gazette 2005/18)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

(30) Priority: 24.10.2003 EP 03103962
27.10.2003 US 513996 P

(71) Applicant: Solvay Pharmaceuticals GmbH
30173 Hannover (DE)

(72) Inventors:
  • ANTEL, Jochen
    31848 Bad Münder (DE)
  • GREGORY, Peter-Colin
    30559 Hannover (DE)
  • KRAUSE, Günter
    31303 Burgdorf (DE)

(74) Representative: Gosmann, Martin 
c/o Solvay Pharmaceuticals GmbH, PH-ZP (IPSI), Hans Böckler Allee 20
30173 Hannover
30173 Hannover (DE)

   


(54) COMBINATION TREATMENT OF OBESITY INVOLVING SELECTIVE CB1-ANTAGONISTS AND LIPASE INHIBITORS